POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus

NCT00423215 ·Status: COMPLETED

Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus

NCT00565162 ·Status: COMPLETED ·Phase: PHASE4

Lantus in Prediabetes

NCT00348972 ·Status: COMPLETED ·Phase: PHASE1

Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes

NCT00553020 ·Status: COMPLETED ·Phase: PHASE4

A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus

NCT00399724 ·Status: COMPLETED ·Phase: PHASE4

Lantus Effect on Myocardial Glucose Metabolism in T2

NCT00335465 ·Status: COMPLETED ·Phase: PHASE4

A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® in Healthy Male Volunteers

NCT05248841 ·Status: COMPLETED ·Phase: PHASE1

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

NCT05035082 ·Status: COMPLETED ·Phase: PHASE4

Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)

NCT00642915 ·Status: COMPLETED ·Phase: PHASE4

Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes

NCT00174681 ·Status: COMPLETED ·Phase: PHASE4

A Study Using Medical Records of Danish People With Type 2 Diabetes Comparing Empagliflozin and Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in the Occurrence of Serious Cardiovascular Outcomes

NCT03993132 ·Status: COMPLETED

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

NCT01794143 ·Status: COMPLETED ·Phase: PHASE3

Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin

NCT00135057 ·Status: COMPLETED ·Phase: PHASE3

PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+Lispro

NCT00540709 ·Status: COMPLETED ·Phase: PHASE4

Opposing Step-by-step Insulin Reinforcement to Intensified Strategy

NCT00174642 ·Status: COMPLETED ·Phase: PHASE3

Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study

NCT00539448 ·Status: COMPLETED ·Phase: PHASE4

A Study in Patients With Type 2 Diabetes Mellitus

NCT01435616 ·Status: COMPLETED ·Phase: PHASE3

Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control

NCT00701831 ·Status: COMPLETED ·Phase: PHASE4

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy

NCT01499095 ·Status: COMPLETED ·Phase: PHASE3

Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus

NCT01689142 ·Status: COMPLETED ·Phase: PHASE3

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin

NCT01499082 ·Status: COMPLETED ·Phase: PHASE3

Study of the Performance of the GLUCUBE System in Patients With Type 2 Diabetes

NCT07075796 ·Status: COMPLETED ·Phase: NA

Equivalence of A Stable Liquid Glucagon Formulation With Freshly Reconstituted Lyophilized Glucagon

NCT02018627 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)

NCT00627471 ·Status: TERMINATED ·Phase: PHASE4

Glycemic Optimization Treatment Study

NCT00552370 ·Status: COMPLETED ·Phase: PHASE4